Opthea (ASX:OPT) secures up to US$260m in funding for OPT-302 trials
Biopharmaceutical company Opthea (OPT) receives binding commitments for a US$90 million (A$127…
Opthea Limited (ASX:OPT)
About Opthea Limited
Key Information
OPT In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 15/11/2024 | Initial Director's Interest Notice | 786.71KB | 250 |
| 15/11/2024 | Price Sensitive PS Opthea Received A$15.9 Million R&D Tax Incentive | 217.04KB | 1.6K |
| 15/11/2024 | Results of Meeting | 342.98KB | 268 |
| 15/11/2024 | Director Appointment/Resignation | 463.08KB | 1.6K |
| 15/11/2024 | Price Sensitive PS Chair's Address to Shareholders | 234.64KB | 659 |
| 12/11/2024 | Opthea's Wet AMD Program Featured at Ophthalmology Events | 457.02KB | 2.4K |
| 04/11/2024 | Update Opthea Participates in November Investor Conferences | 445.94KB | 413 |
| 04/11/2024 | Opthea to Participate in November Investor Conferences | 445.46KB | 374 |